Skip to main content

Acadia Pharmaceuticals Inc

ACAD
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001070494

In the last 90 days, Acadia Pharmaceuticals Inc insiders filed 0 open-market purchases and 2 sales; 354 institutions reported holding it in 13F filings for Q2 2026, worth $4.27B in total; no superinvestor holds it.

Politicians who traded ACAD

Since 2020, newest trade first. Shares and options by default, including trades reported under an earlier ticker.

Trades
2
Filings
2
Politicians
1
Buys / sells
0 / 2
Estimated volume
$16.0K
Sum of range midpoints
Politicians who traded ACAD
PoliticianTradesBuys / sellsEst. volumeLast tradedLast filed
Chris Jacobs House · NY
20 / 2$16.0KJun 16, 2022Jul 28, 2022

Trades

Reported trades in Acadia Pharmaceuticals Inc, newest filings first.

Politician trades
PoliticianAssetTypeOwnerTradedFiledDelayAmountSource
Chris Jacobs House · NY
ACADACADIA Pharmaceuticals Inc.SellSelfJun 16, 2022Jul 28, 202242 days$1K-$15KFiling
Chris Jacobs House · NY
ACADACADIA Pharmaceuticals Inc.Sell (partial)SelfSep 8, 2020Nov 6, 202059 daysLate$1K-$15KFiling

Source: U.S. House Clerk and Senate Office of Public Records (eFD). Amounts are the ranges filers report. Profiles, committees and photos: the unitedstates project (public domain). District maps: U.S. Census Bureau.